Sign up to save your podcasts
Or
Share 3.48 The Predictive Value of High Tumor Mutational Burden with Dr. Luc Morris
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
3.48 The Predictive Value of High Tumor Mutational Burden with Dr. Luc Morris
Today we interview Dr. Luc Morris of Memorial Sloan Kettering Cancer Center on his new paper out now in JAMA Oncology titled "Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase".
Response Rates: doi.org/10.1001/jamaoncol.2020.7684
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
View all episodes
By Vinay Prasad, MD MPH
4.8
743743 ratings
Today we interview Dr. Luc Morris of Memorial Sloan Kettering Cancer Center on his new paper out now in JAMA Oncology titled "Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase".
Response Rates: doi.org/10.1001/jamaoncol.2020.7684
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
More shows like Plenary Session
View all
NEJM This Week
315 Listeners
The Glenn Show
2,245 Listeners
Making Sense with Sam Harris
26,378 Listeners
JAMA Clinical Reviews
476 Listeners
The Curbsiders Internal Medicine Podcast
3,327 Listeners
The ZDoggMD Show
2,947 Listeners
Core IM | Internal Medicine Podcast
1,087 Listeners
The Readout Loud
318 Listeners
The Peter Attia Drive
7,785 Listeners
Annals On Call Podcast
174 Listeners
The VPZD Show
1,725 Listeners
Two Onc Docs
166 Listeners
NEJM AI Grand Rounds
50 Listeners
Sensible Medicine
127 Listeners